Biosorbable Oxygen-Generating Wound Dressing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current wound treatment devices for delivering oxygen to compromised tissues lack biosorbability, wet strength, and practicality for use in surgical incisions, as they are either non-biosorbable or require toxic cross-linking agents, limiting their effectiveness and safety for internal use.

Innovation Solution

A biosorbable oxygen-delivery wound treatment device featuring a cross-linked biosorbable polymer network that forms gas-permeable, elastic closed cells, using biocompatible materials like hyaluronic acid, gelatin, and propylene glycol alginate, with hydrogen peroxide generating oxygen within the matrix, and optionally incorporating active agents for enhanced healing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If a closed cell oxygen-containing foam dressing based on polyacrylamide is used, then oxygen delivery capacity is improved, but biosorbability is lost making it unsuitable for internal use

Engineering Contradiction:
Improveoxygen delivery capacityVSAvoidbiosorbability
Core Design Contradiction:
Quantity of substanceVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical composition parameters of the foam matrix from synthetic polyacrylamide to biosorbable polymers including gelatin, collagen, chitosan, and alginate. This parameter change maintains the closed-cell foam structure and oxygen delivery capability while adding biosorbability for internal surgical use.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite foam material combining multiple biosorbable polymers (gelatin, collagen, chitosan, alginate) with cross-linking agents to achieve both structural integrity and biosorbability. The composite structure incorporates oxygen-generating peroxide compounds within the foam matrix while maintaining biocompatibility.

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If gelatin is used to make a biosorbable oxygen foam dressing, then biosorbability is achieved, but wet strength is insufficient making handling difficult

Engineering Contradiction:
ImprovebiosorbabilityVSAvoidwet strength
Core Design Contradiction:
Adaptability or versatilityVSStrength

Solution Approach 1:

The patent introduces cross-linking agents as intermediaries that form chemical bonds between gelatin and collagen molecules. These cross-links act as structural bridges that maintain wet strength while preserving biosorbability, allowing the foam to handle properly in wet wound environments.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent combines gelatin with collagen and other structural polymers to create a composite matrix where different materials complement each other's properties. The multi-component composite provides both biosorbability from the natural polymers and adequate wet strength through synergistic interactions and cross-linking.

Inventive Principle:
Principle #40Composite materials

3Strength

If cross-linking agents are used to improve wet strength, then handling becomes easier, but toxic cross-linking agents cannot be used for internal surgery

Engineering Contradiction:
Improvewet strengthVSAvoidtoxicity
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The patent employs biocompatible, biodegradable cross-linking agents that are safe for internal use and will be metabolized or excreted by the body. These temporary cross-links provide necessary strength during handling and initial wound contact, then gradually degrade as the wound heals, eliminating long-term toxicity concerns.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the chemical nature of cross-linking agents from permanent, potentially toxic synthetic agents to temporary, biocompatible natural agents. The cross-linking parameters are optimized to provide adequate strength during use while ensuring complete biodegradation, transforming the cross-linking function from permanent structural reinforcement to temporary handling aid.

Inventive Principle:
Principle #35Parameter changes

4Ease of operation

If a biosorbable foam is designed for internal surgical incisions, then the need for dressing removal is eliminated, but adequate wet strength for handling is required

Engineering Contradiction:
Improveease of applicationVSAvoidwet strength
Core Design Contradiction:
Ease of operationVSStrength

Solution Approach 1:

The patent applies cross-linking treatment during the manufacturing process, before the foam is applied to the wound. This preliminary cross-linking establishes the necessary wet strength and structural integrity during handling and application, while the cross-links remain biodegradable for safe internal use during the healing process.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device provides sustained oxygen delivery to wounds, promoting healing while being resorbable, eliminating the need for dressing removal and ensuring safety with non-toxic components, thus enhancing wound care by accelerating healing and reducing complications.

Implementation Method 1

A plurality of gas-permeable, elastic, closed cells are defined by the cross-linked biosorbable polymer network and are produced from a reaction between a catalyst and hydrogen peroxide

Methodology Applied
Scientific EffectChemical reaction (hydrogen peroxide decomposition): Decomposition (biological)

Data Source

PatentUS9381269B2Biosorbable wound treatment device, process for making, and method of using the same
Publication Date: 2016.07.05 AVENT INC
  • US9381269B2 patent drawing
  • US9381269B2 patent drawing
  • US9381269B2 patent drawing

AI summary

A biosorbable oxygen-delivery wound treatment device that includes a biosorbable matrix for delivering oxygen. The biosorbable matrix includes a water swellable, cross-linked biosorbable polymer network. A plurality of gas-permeable, elastic, closed cells is defined by the cross-linked biosorbable polymer network. According to the invention, these closed cells may be produced from a reaction between a catalyst and a second reactant. Deliverable oxygen is contained within the elastic closed cells such that when the device is used to treat a wound, oxygen is delivered from the closed cells. A process for making a biosorbable oxygen-delivery wound treatment device that includes a biosorbable matrix for delivering oxygen as well as a method of using an oxygen-delivery wound treatment device is disclosed.